This message was sent to ##Email##
|
|
|
|
|
Oncology Nurse Advisor
Researchers have discovered a key mechanism by which radiotherapy fails to completely destroy tumors. In a study involving a mouse model described in Nature Immunology, the investigators offer a novel solution to promote successful radiotherapy for the millions of cancer patients who receive this treatment.
READ MORE
Scientific American
The worst cancer cells don't sit still. Instead they metastasize — migrate from their original sites and establish new tumors in other parts of the body. Once a cancer spreads, it is harder to eliminate. A study by developmental biologists offers a fresh clue to how cancer cells acquire the ability to invade other tissues — a prerequisite for metastasis. It reveals that invasion requires cells to stop dividing. Therefore, the two processes — invasion and proliferation — are mutually exclusive. The finding could inform cancer therapies, which typically target rapidly proliferating cancer cells.
READ MORE
ACS
The Commission on Cancer (CoC) of the American College of Surgeons (ACS) has released the Standards Manual for the Oncology Medical Home (OMH) Accreditation Program. The standards are established around the OMH model that provides comprehensive and continuous medical care to patients with the goal of obtaining maximized health outcomes.
READ MORE
Medscape
Cancer patients often need therapeutic anticoagulation for venous thromboembolism, but they often have coexisting chemotherapy-induced thrombocytopenia. "This is clinically very important," commented Gerald Soff, M.D., chief of the Hematology Service at the Memorial Sloan Kettering Cancer Center in New York. "Every day, in every cancer clinic around the world, the question comes up on how to manage blood thinners and how to manage cancer patients with severely reduced platelet counts," he said.
READ MORE
 |
|
Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text.
|
|
Medical News Today
A long-term clinical trial of a gene therapy for prostate cancer that causes the immune system to attack tumor cells suggests it is effective and safe, researchers say.
READ MORE
Forbes
Cancer used to be considered a killer of the affluent — a Western disease — in contrast to communicable diseases known to plague developing nations. But as populations everywhere grow, live longer and adopt lifestyle behaviors that increase cancer risk, the number of cancer cases and deaths is predicted to grow rapidly.
READ MORE
CoC
If you are affiliated with a CoC-accredited program, please make sure that program responds to the Call for Data to ensure compliance with CoC Standards 5.5 (Data Submission), 5.6, (Accuracy of Data) and requirements for submission deadline extensions. Read this announcement from the NCDB to learn more.
Cornell University via Medical Xpress
Pre-existing inflammation in the lungs may increase the risk that cancers beginning elsewhere will spread to that organ, according to new research from Weill Cornell Medicine. Physicians have long noted an association between lung inflammation — seen in smokers or in people with lung diseases such as asthma, COPD and emphysema, and pneumonia — and the development of lung tumors. But it's been unclear whether inflammation also increases the risk of pulmonary metastasis from other tumors.
READ MORE
Medical News Today
Within the past decade, it has emerged that cells package various molecules into tiny bubble-like parcels called extracellular vesicles to send important messages — in sickness and health. The potential for using these vesicles in diagnosis and treatment is now under intense investigation.
READ MORE
ACS
It is not too late! You may purchase the Webcast packages to view the sessions you were not able to attend at Clinical Congress. Webcast sessions are available on your computer, tablet or mobile device anytime, anywhere. Maximize your learning opportunities and earn CME Credit and Self-Assessment Credit when it's convenient for you. Click here to see more.
Medscape
The risks for late lung cancer and ischemic heart disease among women who undergo irradiation for breast cancer are both reassuringly low, unless the patient is a smoker who just can't kick the habit, said investigators from the Early Breast Cancer Trialists' Collaborative Group. "In our data, the main risks of breast cancer radiotherapy were cardiac mortality and lung cancer, and in nonsmokers, even taking those two risks together, the overall absolute risk was well under 1 percent, and that's good news for many women," said Carolyn Taylor, M.D., a radiation oncologist at Oxford University in the United Kingdom.
READ MORE
ACS
Follow the CoC (@COC_ACS) and the NAPBC (@NAPBC_ACS) on Twitter. Make sure you also like the NAPBC Facebook page.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
